Allergy/Imm Medical News about influenza vaccine

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children
Vaccine , 08/24/09

Breiman RF et al. – Response rates for different poliovirus types were similar in recipients of LAIV + OPV and placebo + OPV. Response rates to all influenza strains were similar in LAIV + OPV and LAIV–only recipients. Concomitant OPV and LAIV were safely administered to young children.

<< Previous
Reproducibility of food atopy patch tests over time in the...

Next >>
The first safe inactivated equine influenza vaccine formulation...

Update on 2009 pandemic influenza A (H1N1) virus
Cleveland Clinic Journal of Medicine, 10/05/09 Relevance Score: 71%

Pandemic 2009 Influenza Update: Pandemrix data on co-administration with annual seasonal influenza vaccine
GlaxoSmithKline, 11/10/09 Relevance Score: 70%

H1N1 Vaccine Deliveries Begin. Early Doses to Arrive This Week
American Family Physician, 10/07/09 Relevance Score: 70%

Novartis completes shipment of US supply of Fluvirin seasonal influenza vaccine
Novartis, 10/07/09 Relevance Score: 70%

One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17. Younger Children Likely Will Need Two Doses
American Family Physician, 10/05/09 Relevance Score: 70%